Role of interleukin-8 in tumor growth and metastasis of human melanoma

Pathobiology

Volumn 67, Issue 1, 1999, Pages 12-18

  Bar Eli, Menashe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Collagenase; Interleukin 8; Melanoma; Metastasis

Indexed keywords

GELATINASE A; INTERLEUKIN 8;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; MELANOMA; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CELL HYPOXIA; DISEASE PROGRESSION; GELATINASES; HUMANS; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 2; MELANOMA; METALLOENDOPEPTIDASES; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASMS, RADIATION-INDUCED; NEOVASCULARIZATION, PATHOLOGIC; SKIN; SKIN NEOPLASMS; TRANSFECTION; ULTRAVIOLET RAYS;

ANIMALIA; MUS MUSCULUS;

EID: 0032960519     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028045     Document Type: Article

References (66)

1. Rigel DS, Kopf AW, Friedman RJ: The rate of malignant melanoma in the United States: Are we making an impact? J Am Acad Dermatol 1987;17:1050-1053.
2. Fidler IJ: Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 1990;50:6130-6138.
3. Lu C, Kerbel RS: Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma. Curr Opin Oncol 1994;6:212-220.
4. Radinsky R: Growth factors and their receptors in metastasis. Semin Cancer Biol 1991;2: 169-177.
5. Matte S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M: Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994;56:853-857.
6. Kerbel RS: Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Am J Pathol 1992;141:519-524.
7. Herlyn M: Human melanoma development and progression. Cancer Metastasis Rev 1990; 9:101-112.
8. Richmond A, Lawson DH, Nixon DW, Stedman NJ, Stevens S, Chawla RK: Extraction of a melanoma-growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line. Cancer Res 1983; 43:2106-2112.
9. DeLarco JE, Pigott DA, Lazarus JA: Ectopic peptides released by a human melanoma cell line that modulate the transformed phenotype. Proc Natl Acad Sci USA 1985;82:5015-5019.
10. Westermark B, Johnsson A, Paulsson Y, Betsholtz C, Heldin CH, Herlyn M, Rodeck U, Koprowski H: Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor and produce a PDGF-like growth factor. Proc Natl Acad Sci USA 1986;83:7197-7200.
11. Halaban R, Kwon BS, Ghosh S, Delli Bovi P, Baird A: bFGF as an autocrine growth factor for human melanoma. Oncogene Res 1988;3: 177-186.
12. Kock A, Schwarz T, Urbanski A, Peng Z, Vetterlein M, Miksche M, Ansel C, Kung HF, Luger TA: Expression and release of interleukin-1 by different human melanoma cell lines. J Natl Cancer Inst 1989;81:36-42.
13. Bennicelli JL, Elias J, Kern J, Guerry D: Production of interleukin-1 activity by cultured human melanoma cells. Cancer Res 1989;49: 930-935.
14. Lu C, Vickers MF, Kerbel RS: Interleukin-6: A fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA 1992;89:9215-9216.
15. Chen QY, Daniel V, Maher DW, Hersey P: Production of IL-10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma. Int J Cancer 1995;56: 755-760.
16. Huang S, Xie K, Bucana CD. Ullrich SE, BarEli M: Interleukin-10 suppresses tumor growth and metastasis of human melanoma cells: Potential inhibition of angiogenesis. Clin Cancer Res 1996;2:1969-1979.
17. Armstrong CA, Tara DC, Hart CE, Kock A, Luger TA, Ansel JC: Heterogeneity of cytokine production by human malignant melanoma cells. Exp Dermatol 1992;1:37-45.
18. desarg and an anionic neutrophil activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 1986;87:53-58.
19. Walz A, Peveri P, Aschauer AO, Baggiolini M: Purification and amino acid sequencing of NAF, a novel neutrophil activating factor produced by monocytes. Biochem Biophys Res Commun 1987;149:755-761.
20. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene, intercrine cytokine family. Annu Rev Immunol 1991;9:617-648.
21. Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M, Czarnetzki B: IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993;151:2667-2675.
22. Scheibenbogen C, Mohler T, Haefele J, Hunstein W, Keilholz U: Serum interleukin-8 is elevated in patients with metastatic melanoma and correlates with tumor load. Melanoma Res 1995;5:179-181.
23. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ: Expression of interleukin-8 correlates with metastatic potential of human melanoma cells in nude mice. Cancer Res 1994;54: 3242-3247.
24. Wang JM, Taroboletti G, Matsushima K, Damme JV, Mantovani A: Induction of haptotactic migration of melanoma cells by neutrophil activating protein/IL-8. Biochem Biophys Res Commun 1990;169:165-170.
25. Keane MP, Arenberg DA, Lynch JP III, White RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL, Stricter RM: The CXC chemokines, IL-8 and IP-10 regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997; 159:1437-1443.
26. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, Einer SG, Stricter RM: Interleukin-8 as a macrophage derived mediator of angiogenesis. Science 1992;258: 1798-1801.
27. Strieter RM, Kunkel SL, Einer VM, Martonyi CL, Koch AE, Polverini PJ, Einer SG: Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 1992;141:1279-1284.
28. Holman CDJ, Mulroney CD, Armstrong BK: Epidemiology of preinvasive and invasive malignant melanoma in Western Australia. Int J Cancer 1980;25:317-323.
29. Romerdahl CA, Donawho C, Fidler IJ, Kripke ML: Effect of UV-B radiation on the in vivo growth of murine melanoma cells. Cancer Res 1988;48:4007-4010.
30. Romerdahl CA, Stephens LC, Bucana CD, Kripke ML: The role of ultraviolet radiation in the induction of melanocytic skin tumors in inbred mice. Cancer Commun 1989;11:209-216.
31. Donawho CK, Kripke ML: Evidence that the local effect of UV radiation on the growth of murine melanomas is immunologically mediated. Cancer Res 1991;41:4176-4181.
32. Donawho CK, Wolf P, Kripke ML: Enhanced development of murine melanoma in UV irradiated skin: UV dose response, waveband dependence, and relation to inflammation. Melanoma Res 1994;4:93-100.
33. Griswold DE, Connor JR, Dalton BJ, Lee JC, Simon P, Hillegass L, Sieg DJ, Hanna N: Activation of the IL-1 gene in UV-irradiated mouse skin: Association with inflammatory sequelae and pharmacologic intervention. J Invest Dermatol 1991;97:1019-1023.
34. Kondo SK, Kono T, Sauder DN, McKenzie RC: IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol 1993;101:690-694.
35. Schwarz T, Luger TA: Effect of UV irradiation on epidermal cell cytokine production. J Pharmacol Photobiol 1989;4:1-13.
36. Ansel JC, Luger TA, Green I: The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes. J Invest Dermatol 1983;81:519-523.
37. Urbanski A, Schwarz T, Neuner P, Krutmann J, Kirnbauer R, Kock A, Lager TA: Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol 1989;94:808-811.
38. Rivas JM, Ullrich SE: Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 1992;149:3865-3871.
39. Grewe M, Gyufko K, Krutman J: Interleukin-10 production by cultured human keratinocytes: Regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol 1995;104: 3-6.
40. Kock A, Schwarz T, Kimbauer R, Urbanski A, Perry P, Ansel JC, Luger A: Human keratinocytes are a source of tumor necrosis factor a: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990;172:1609-1614.
41. Verschragen CE, Giovanella BC, Mendoza JT, Kozielsky AI, Stehlin JS Jr: Specific organ metastasis of human melanoma cells injected into the arterial circulation of nude mice. Anticancer Res 1991;11:529.
42. Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ, Bar-Eli M: Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res 1993;3:35-41.
43. Singh RK, Gutman M, Reich R, Bar-Eli M: Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin-8. Cancer Res 1995;55:3669-3674.
44. INK4/MTS-1) gene in human melanoma cells: Relevance to tumor growth and metastasis. Oncogene 1995;11:1399-1402.
45. Xie K, Huang S, Luca M, Gutman M, Reich R, Johnson JP, Bar-Eli M: Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res 1997;57:2295-2303.
46. Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M: Interleukin-10 suppresses tumor growth and metastasis of human melanoma cells: Potential inhibition of angiogenesis. Clin Cancer Res 1996;2:1969-1979.
47. Bar-Eli M: Molecular mechanisms of melanona metastasis. J Cell Physiol 1997;173:275-278.
48. Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M: Expression of interleukin-8 by human melanoma cells upregulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 1997;151:1105-1113.
49. Ballin M, Gomez DE, Sinha CC, Thorgeirsson UP: Ras oncogene mediated activation of a 92 kDa metalloproteinase showing correlation with the malignant phenotype. Biochem Biophys Res Commun 1988;154:832-838.
50. Gutman M, Singh RK, Xie K, Bucana CD, Fidler IJ: Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res 1995;55:2470-2472.
51. Singh RK, Bucana CD, Gutman M, Fan D, Wilson MR, Fidler IJ: Organ-site dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am J Pathol 1994;145:365-374.
52. Fabra A, Nakajima M, Bucana CD, Fidler IJ: Modulation of the invasive phenotype of human colon carcinoma cells by organ-specific fibroblasts of nude mice. Differentiation 1992; 52:110.
53. Wilmanns C, Fan D, O'Brian CA, Bucana CD, Fidler IJ: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 1992;52: 98-104.
54. Desbaillets I, Diserens AC, de Tribolet N, Hamou MF, van Meir EG: Upregulation of interleukin-8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 1997;8: 1201-1212.
55. Karakurum M, Shreeniwas R, Chen J, Pinky D, Yan SD, Anderson M, Sunouchi K, Major J, Hamilton T, Kuwabara K, Rot A, Novygrod R, Stern D: Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994;93:1564-1570.
56. Mukaida N, Mahe Y, Matsushima K: Cooperative interaction of nuclear factor-kB- and cisregulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 1990;265:21128-21133.
57. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, Matsushima K: Novel mechanisms of glucocorticoid-mediated gene repression. Nuclear factor-kB is target for glucocorticoid-mediated interleukin-8 gene repression. J Biol Chem 1994;269:13289-13295.
58. Murayama T, Ohara Y, Obuchi M, Khabar KSA, Higashi H, Mukaida N, Matsushima K: Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1 and NF-kB-binding sites of the interleukin-8 gene. J Virol 1997;71:5692-5695.
59. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K: Tumor necrosis factor α and Interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB like binding sites of the interleukin 8 gene. J Biol Chem 1992;267: 22506-22511.
60. Singh RK, Gutman M, Llansa N, Fidler IJ: Interferon-β prevents the upregulation of interleukin-8 expression in human melanoma cells. J Interferon Cytokine Res 1996;16:577-584.
61. Singh RK, Varney ML: Regulation of interleukin 8 expression in human malignant melanoma cells. Cancer Res 1998;58:1532-1537.
62. Shih IM, Elder DE, Hsu MY, Herlyn M: Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Pathol 1994;145:837-845.
63. Kupper TS, Ballard D, Chua AO, McGuire JS, Flood P, Horowitz MC, Langdon R, Lightfoot L, Gubler U: Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 mRNA. J Exp Med 1986;164:2095-2100.
64. Oxholm A, Oxholm P, Staberg B, Bendtzen K: Immunohistological detection of interleukin-1-like molecules and tumor necrosis factor in human epidermis before and after UV-B irradiation in vivo. Br J Dermatol 1988;118:369-376.
65. Kirnbauer R, Kock A, Schwartz T, Urbanski A, Krutman J, Borth Q, Ansel JC, Luger TA: Interferon-β2, B-cell differentiation factor 2, hybridoma growth factor (interleukin-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 1989;142:1922-1928.
66. Yaar M, Palleroni AV, Gilchrest BA: Keratinocytes contain an interferon like protein that may modulate their growth and differentiation. Ann NY Acad Sci 1988;548:299-311.